Search

Pallaiah S Thammana

from Silver Spring, MD
Age ~79
Get Report
Also known as:
Pallaiah Rani Thammana, Pallaiah R Thammana, Rani Thammana, Thammana Pallaiah, H Thammana
Phone and address:
11200 Lockwood Dr APT 1804, Silver Spring, MD 20901
(315) 378-7133
Related to:
Venkata PuttaguntaVilga ThammanaDurga ThammanaChandra Puttagunta, 76
Connected to:
Anitha Thammana, 46Angie J Thammavong, 30Pangkham Thammavong, 39Ron A Thammavong, 33Scott S Thammavong, 42Steven Thammavong, 40Youpharath Thammavong, 50Bhaskar Thammineni, 48Kalyan C Thammineni, 38Daniel K Thamotheram, 50

Pallaiah Thammana Phones & Addresses

  • 11200 Lockwood Dr APT 1804, Silver Spring, MD 20901 (315) 378-7133
  • 4410 Jack In The Pulpit Cir, Manlius, NY 13104 (315) 682-4847
  • Newark, DE
  • Medway, MA
  • Langhorne, PA
  • Bronx, NY
  • 11200 Lockwood Dr APT 1804, Silver Spring, MD 20901

Work

Position: Executive, Administrative, and Managerial Occupations

Education

Degree: High school graduate or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Pallaiah Thammana
Principal
Thammana Durga
Business Services at Non-Commercial Site
4410 Jack In The Pulpit Cir, Manlius, NY 13104

Publications

Us Patents

Expression Vectors Containing Hot Spot For Increased Recombinant Protein Expression In Transfected Cells

View page
US Patent:
6521419, Feb 18, 2003
Filed:
Aug 31, 1999
Appl. No.:
09/386816
Inventors:
Kanakaraju Koduri - Fayetteville NY, 13066
John T. Miller - Syracuse NY, 13206
Pallaiah Thammana - Manlius NY, 13104
International Classification:
C12P 2102
US Classification:
435 691, 435358, 4353201, 536 242
Abstract:
A specific locus (hot spot) for recombinant gene expression has been identified in the genome of Chinese hamster ovary cells. A DNA vector containing the hot spot causes high levels of recombinant gene expression following transfection and stable integration. The selection and cloning of the specific locus and the expression of recombinant genes is disclosed, as are the DNA vectors and the host cells.

Expression Vectors Containing Hot Spot For Increased Recombinant Protein Expression In Transfected Cells

View page
US Patent:
6800457, Oct 5, 2004
Filed:
Dec 16, 2002
Appl. No.:
10/320176
Inventors:
Kanaka Raju Koduri - White Plains NY
John T. Miller - Syracuse NY
Pallaiah Thammana - Manlius NY
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C12P 2102
US Classification:
435 691, 435 696, 435358, 4353201
Abstract:
A specific locus (hot spot) for recombinant gene expression has been identified in the genome of Chinese hamster ovary cells. A DNA vector containing the hot spot causes high levels of recombinant gene expression following transfection and stable integration. The selection and cloning of the specific locus and the expression of recombinant genes is disclosed, as are the DNA vectors and the host cells.

Compositions And Methods For Producing A Composition

View page
US Patent:
20090252749, Oct 8, 2009
Filed:
Dec 19, 2006
Appl. No.:
12/086786
Inventors:
Kirk J. Leister - Fayetteville NY, US
Eugene J. Schaefer - Westfield NJ, US
Ronald Charles Bates - Irvine CA, US
Elizabeth A. Bramhall - Groton MA, US
David Michael Didio - Syracuse NY, US
Robert Donaldson - Southborough MA, US
Alan R. Flesher - Lawrenceville NJ, US
Helen Gray Haggerty - Manlius NY, US
David Henry Kirkley - East Syracuse NY, US
John Malcolm Tabor - Syracuse NY, US
Lee K. Tay - Princeton Junction NJ, US
Pallaiah Thammana - Manlius NY, US
Ajoy Velayudhan - Cary NC, US
David Edward Smolin - Pennington NJ, US
Reb J. Russell - Doylestown PA, US
Thomas James Vanden Boom - Flemington NJ, US
Dean Woodrow Brownell - Oswego NY, US
Jeffrey Schrimsher - Hillsborough NC, US
Joyce Patricia Whitehead - Manlius NY, US
International Classification:
A61K 39/395
C07K 16/18
C12P 21/00
C07K 1/14
C07K 1/18
US Classification:
4241781, 5303911, 435 691, 530412, 530416
Abstract:
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.

Compositions And Methods For Producing A Composition

View page
US Patent:
20210246188, Aug 12, 2021
Filed:
Nov 25, 2020
Appl. No.:
17/105358
Inventors:
- Princeton NJ, US
Eugene J. Schaefer - Westfield NJ, US
Ronald Charles Bates - Irvine CA, US
Elizabeth A. Bramhall - Groton MA, US
David Michael Didio - Syracuse NY, US
Robert Donaldson - Southborough MA, US
Alan R. Flesher - Lawrenceville NJ, US
Helen Gray Haggerty - Manlius NY, US
David Henry Kirkley - East Syracuse NY, US
John Malcolm Tabor - Syracuse NY, US
Lee K. Tay - Princeton Junction NJ, US
Pallaiah Thammana - Manlius NY, US
Ajoy Velayudhan - Cary NC, US
David Edward Smolin - Pennington NJ, US
Reb J. Russell - Doylestown PA, US
Thomas James Vanden Boom - Flemington NJ, US
Dean Woodrow Brownell - Oswego NY, US
Jeffrey Schrimsher - Hillsborough NC, US
Joyce Patricia Whitehead - Manlius NY, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 14/705
A61K 38/19
C07K 16/28
Abstract:
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.

Carbohydrate Content Of Ctla4 Molecules

View page
US Patent:
20200017569, Jan 16, 2020
Filed:
Jul 24, 2018
Appl. No.:
16/044252
Inventors:
- Princeton NJ, US
Eugene J. Schaefer - Westfield NJ, US
Ronald Charles Bates - Irvine CA, US
Elizabeth A. Bramhall - Groton MA, US
David Michael Didio - Syracuse NY, US
Robert Donaldson - Southborough MA, US
Alan R. Flesher - Lawrenceville NJ, US
Helen Gray Haggerty - Manlius NY, US
David Henry Kirkley - East Syracuse NY, US
John Malcolm Tabor - Syracuse NY, US
Lee K. Tay - Princeton Junction NJ, US
Pallaiah Thammana - Manlius NY, US
Ajoy Velayudhan - Cary NC, US
David Edward Smolin - Pennington NJ, US
Reb J. Russell - Doylestown PA, US
Thomas James Vanden Boom - Flemington NJ, US
Dean Woodrow Brownell - Oswego NY, US
Jeffrey Schrimsher - Hillsborough NC, US
Joyce Patricia Whitehead - Manlius NY, US
International Classification:
C07K 14/705
A61K 38/19
C07K 16/28
A61K 38/00
B01D 15/38
Abstract:
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.

Compositions And Methods For Producing A Composition

View page
US Patent:
20190092835, Mar 28, 2019
Filed:
Jul 24, 2018
Appl. No.:
16/044217
Inventors:
- Princeton NJ, US
Eugene J. Schaefer - Westfield NJ, US
Ronald Charles Bates - Irvine CA, US
Elizabeth A. Bramhall - Groton MA, US
David Michael Didio - Syracuse NY, US
Robert Donaldson - Southborough MA, US
Alan R. Flesher - Lawrenceville NJ, US
Helen Gray Haggerty - Manlius NY, US
David Henry Kirkley - East Syracuse NY, US
John Malcolm Tabor - Syracuse NY, US
Lee K. Tay - Princeton Junction NJ, US
Pallaiah Thammana - Manlius NY, US
Ajoy Velayudhan - Cary NC, US
David Edward Smolin - Pennington NJ, US
Reb J. Russell - Doylestown PA, US
Thomas James Vanden Boom - Flemington NJ, US
Dean Woodrow Brownell - Oswego NY, US
Jeffrey Schrimsher - Hillsborough NC, US
Joyce Patricia Whitehead - Manlius NY, US
International Classification:
C07K 14/705
C07K 16/28
A61K 38/19
A61K 38/00
B01D 15/38
Abstract:
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.

Carbohydrate Content Of Ctla4 Molecules

View page
US Patent:
20190062399, Feb 28, 2019
Filed:
Jul 23, 2018
Appl. No.:
16/042977
Inventors:
- Princeton NJ, US
Eugene J. Schaefer - Westfield NJ, US
Ronald Charles Bates - Irvine CA, US
Elizabeth A. Bramhall - Groton MA, US
David Michael Didio - Syracuse NY, US
Robert Donaldson - Southborough MA, US
Alan R. Flesher - Lawrenceville NJ, US
Helen Gray Haggerty - Manlius NY, US
David Henry Kirkley - East Syracuse NY, US
John Malcolm Tabor - Syracuse NY, US
Lee K. Tay - Princeton Junction NJ, US
Pallaiah Thammana - Manlius NY, US
Ajoy Velayudhan - Cary NC, US
David Edward Smolin - Pennington NJ, US
Reb J. Russell - Doylestown PA, US
Thomas James Vanden Boom - Flemington NJ, US
Dean Woodrow Brownell - Oswego NY, US
Jeffrey Schrimsher - Hillsborough NC, US
Joyce Patricia Whitehead - Manlius NY, US
International Classification:
C07K 14/705
C07K 16/28
A61K 38/19
A61K 38/00
B01D 15/38
Abstract:
The invention provides for mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides for compositions comprising CTLA4-Ig and formulations thereof. The invention further provides for methods for mass-producing CTLA4-Ig from mammalian cells capable of producing this recombinant protein, and for purifying the CTLA4-Ig.
Control profile
Pallaiah S Thammana from Silver Spring, MD, age ~79 Get Report